MX359181B - Hidrolizado de colágeno y uso del mismo. - Google Patents

Hidrolizado de colágeno y uso del mismo.

Info

Publication number
MX359181B
MX359181B MX2014006420A MX2014006420A MX359181B MX 359181 B MX359181 B MX 359181B MX 2014006420 A MX2014006420 A MX 2014006420A MX 2014006420 A MX2014006420 A MX 2014006420A MX 359181 B MX359181 B MX 359181B
Authority
MX
Mexico
Prior art keywords
collagen hydrolysate
hydrolysate
collagen
treating
relates
Prior art date
Application number
MX2014006420A
Other languages
English (en)
Other versions
MX2014006420A (es
Inventor
Stephan Hausmanns
Steffen Oesser
Hans-Ulrich Frech
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102011055800A external-priority patent/DE102011055800A1/de
Priority claimed from DE201210101911 external-priority patent/DE102012101911A1/de
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of MX2014006420A publication Critical patent/MX2014006420A/es
Publication of MX359181B publication Critical patent/MX359181B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un hidrolizado de colágeno, para usarse como un ingrediente activo en el tratamiento y/o prevención de celulitis, en donde al menos 90% en peso del hidrolizado de colágeno tiene un peso molecular de menos de 3, 500 Da, y de manera preferida al menos 45% en peso del hidrolizado de colágeno tiene un peso molecular de menos de 1, 500 Da.
MX2014006420A 2011-11-29 2012-11-21 Hidrolizado de colágeno y uso del mismo. MX359181B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011055800A DE102011055800A1 (de) 2011-11-29 2011-11-29 Verwendung von Kollagenhydrolysat
DE201210101911 DE102012101911A1 (de) 2012-03-07 2012-03-07 Verwendung von Kollagenhydrolysat
PCT/EP2012/073180 WO2013079373A1 (de) 2011-11-29 2012-11-21 Kollagenhydrolysat und dessen verwendung

Publications (2)

Publication Number Publication Date
MX2014006420A MX2014006420A (es) 2014-07-30
MX359181B true MX359181B (es) 2018-09-17

Family

ID=47263289

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014006420A MX359181B (es) 2011-11-29 2012-11-21 Hidrolizado de colágeno y uso del mismo.

Country Status (12)

Country Link
US (1) US20140255485A1 (es)
EP (1) EP2785420B1 (es)
JP (2) JP2015504440A (es)
CN (1) CN104010697B (es)
AU (1) AU2012344135B2 (es)
BR (1) BR112014011481B1 (es)
CA (1) CA2854856C (es)
ES (1) ES2669318T3 (es)
MX (1) MX359181B (es)
PL (1) PL2785420T3 (es)
RU (1) RU2635995C2 (es)
WO (1) WO2013079373A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104800094B (zh) * 2014-01-27 2018-03-27 上海拜瑞曼克生物科技有限公司 一种防妊娠纹腹膜
CL2015000593A1 (es) * 2015-03-11 2016-01-22 Alfredo Rodríguez Cerda Patricio Composición cosmética reductiva de aplicación tópica que contiene queratina, azufre, aceite de castor, surfactantes y agua.
JP6578323B2 (ja) * 2017-06-29 2019-09-18 肇 小座野 フィラグリン産生促進剤
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN108949885A (zh) * 2018-08-16 2018-12-07 东北农业大学 一种对成骨细胞增殖具有促进作用的猪皮明胶肽的制备方法及应用
JP7095536B2 (ja) * 2018-10-01 2022-07-05 ユーハ味覚糖株式会社 粘膜保護関連遺伝子発現促進剤およびその用途
DE102018133374A1 (de) * 2018-12-21 2020-06-25 Gelita Ag Kollagenhydrolysat zur Verwendung gegen Hautkrankheiten und Darmkrankheiten
DE102019130196A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Kollagenpeptiden aus Knochen, und hergestellte Kollagenpeptide
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making
CN112056550A (zh) * 2020-07-27 2020-12-11 光亚生物科技(广州)有限公司 一种滋补活性小分子鹿胶膏及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301761A1 (en) * 2002-10-29 2004-05-25 Medical Nutrition Usa, Inc. Method for treating wounds to promote healing
JP2005053798A (ja) * 2003-08-04 2005-03-03 Nonogawa Shoji Kk フィブロネクチン生成促進剤
JP5689222B2 (ja) 2006-11-15 2015-03-25 株式会社明治 コラーゲンペプチド組成物及びこれを含有する飲食品
CN101518645A (zh) * 2008-02-29 2009-09-02 李勇 海洋胶原肽在制备保护肾脏功能、延缓慢性肾衰进程药物、保健食品或食品中的用途
FR2930154B1 (fr) * 2008-04-21 2012-04-20 Oreal Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau
CN102131492B (zh) * 2008-08-27 2013-04-24 株式会社太平洋 含胶原肽的皮肤美容用组合物
DE102009030351A1 (de) * 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
WO2011011808A1 (en) * 2009-07-30 2011-02-03 Roman Buga A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid
DE102010060564A1 (de) * 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel

Also Published As

Publication number Publication date
WO2013079373A1 (de) 2013-06-06
BR112014011481A2 (pt) 2017-05-09
MX2014006420A (es) 2014-07-30
JP2018043999A (ja) 2018-03-22
US20140255485A1 (en) 2014-09-11
ES2669318T3 (es) 2018-05-24
JP2015504440A (ja) 2015-02-12
EP2785420B1 (de) 2018-03-14
RU2014126216A (ru) 2016-01-27
BR112014011481B1 (pt) 2019-02-05
AU2012344135B2 (en) 2017-01-05
AU2012344135A1 (en) 2014-06-26
EP2785420A1 (de) 2014-10-08
CA2854856C (en) 2020-03-10
CN104010697A (zh) 2014-08-27
RU2635995C2 (ru) 2017-11-17
PL2785420T3 (pl) 2018-08-31
JP6462101B2 (ja) 2019-01-30
CA2854856A1 (en) 2013-06-06
CN104010697B (zh) 2017-09-08

Similar Documents

Publication Publication Date Title
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
MX2014011134A (es) Compuestos de carbamato y preparacion y uso de los mismos.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
AU339376S (en) Sterilizing case
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
PL2916855T3 (pl) Hydrolizat kolagenu i jego zastosowanie
SMT201700415T1 (it) Composizioni di c1-inh per l’uso nella prevenzione e nel trattamento dell’angioedema ereditario (hae)
MX359769B (es) Metodos para descelularizar huesos.
IN2014CN04014A (es)
GB2498325A (en) Modulation neural pathways
EP2897689A4 (en) COMPOSITIONS AND METHODS OF TREATING ALOPEZIA
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
IN2014DN08385A (es)
PH12013501205A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
IN2014DN11078A (es)
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
IN2014DN00254A (es)
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
BR112015002531A2 (pt) composição, método de tratamento de hipersensibilidade e uso de carbonato de cálcio.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
IT1406153B1 (it) Metodi di prevenzione e terapia per parti e nascite pretermine.

Legal Events

Date Code Title Description
FG Grant or registration